57
The OPUS –trial: A randomised multicentre single- blinded trial of specialised assertive treatment versus standard treatment for patients with a first episode of psychotic illness – five-years follow-up. Professor Merete Nordentoft Psychiatric Center Bispebjerg, Copenhagen University [email protected] www.opus-kbh.dk

The OPUS –trial: A randomised multicentre single- blinded ... · •Multidisciplinary team, caseload 1:10 •Team follows the patients during in - and outpatient treatment •Flexible

Embed Size (px)

Citation preview

The OPUS –trial:

A randomised multicentre single-

blinded trial of specialised assertive

treatment versus standard treatment for

patients with a first episode of psychotic

illness – five-years follow-up.

Professor Merete Nordentoft

Psychiatric Center Bispebjerg, Copenhagen University

[email protected]

www.opus-kbh.dk

The Danish OPUS Trial: A two-site randomised clinical trial of

assertive specialised psychiatric treatment

First episode psychosis

Five-year follow-up

• The name OPUS was taken from the music

• It means: Piece of work

• We wanted to indicate the need of coordination of different elements in psychiatric treatment

• -and that these elements play together

• We hoped to build an instrument that could play many different keys and tunes

• We conducted a pragmatic trial

A long awaited guest

� A long awaited guest who you want to

feel welcome and at home during a long

visit.

� A collaborator, whose insights and

attitudes are decisive for the outcome.

� An individual with personal preferences

that should be taken into account in the

treatment to the greatest extent possible.

Specialised Assertive

Intervention by OPUS team

•Assertive Community Treatment

–(staff: patient ratio1:10)

•Psychoeducational multi family groups

•Social skills training

The OPUS team

• Psychiatrist

• Psychiatric nurse

• Psychologist

• Social worker

• Vocational therapist

• Labour market/ educational guide

Assertive Community Treatment

•Multidisciplinary team, caseload 1:10

•Team follows the patients during in - and

outpatient treatment

•Flexible frequency of contact (weekly)

•Home visits

•Coordinate different institutions involved in

the treatment of the patient. GP, somatic

department, creditors and social services.

For instance how to respond to an unpleasant official letter

Or how to respond when neighbours complain about

too much wornout furniture placed in the corridor

Or what kind of job training will be relevant?

The OPUS Program for

involving the family:

• Consequently involving families

• Survival skills workshops for relatives

• Single family sessions with crisis intervention with

and/or without the patient

• McFarlanes model for psychoeducational multi-

family groups, every second week for 1½ year.

• On – going possibility for contact to the patient’s

primary team member

Attitudes towards relatives:

•The closest collaborating partners

•Who can be of invaluable help

•Who are very involved in relation to the patient

•A ressource that cannot be equalled

The multi-family group

• 4 - 6 patients and their relatives

• The group meets for 1½ years

• The group meets every second week for

1½- hour meetings

• The method is problem solving

Common problems

•Medication side effects

• Drug abuse

• Job seeking

• Going to school

• Moving away from home

• Maintaining relations

• Conversation

• Parents holiday

The approach

The intervention is personal and warm:

•Show you are interested

•Create a bond between you and the family

•Serve as the advocate of the family

•Create a respectful and not too asymmetric alliance

GuidelinesA list of guidelines and ideas for the family, which can make

family life run more smoothly• Take it easy. It takes time to recover. It is important to rest.

• Keep cool. It is good to be eager, but it can be too much.

• Give room to each other. It is important to have time and room for one’s self.

• Set limits. Everybody needs to know the house rules. It is ok to ask for help, and it is ok to say no.

• Try to accept things, which cannot be changed. Let some things pass. Violence must never be accepted.

• Try to simplify everyday life and conversation. Make the communication clear, calm and positive.

• Be aware of early warning signals for relapse of psychosis. Talk with the contact person about this.

• Solve one problem at a time. Let changes come gradually.

• Lower your expectations. Use a personal measure. Compare this month with last month.

Inclusion CriteriaAge 18-45

A diagnosis (ICD10 research criteria) of F2: schizophrenia, schizotypal disorder, delusional disorder, acute

psychosis, schizoaffective psychosis or unspecific non-organic

psychosis

Patients have so far not had adequate treatment,

defined as 12 weeks of anti-psychotic medication

Assessments• SCAN (Schedule for Clinical Assessment in Neuropsychiatry)

• SAPS (Schedule for Assessment of Positive Symptoms)

• SANS (Schedule for Assessment of Negative Symptoms)

• GAF (function and symptoms)

• Demographic data including educational, employment and

housing status

• Lancashire Quality of life Scale

• Client Satisfaction Questionnaire

• Life Chart Schedule

• Cognitive test (only at 5 years follow-up)

Registerbased follow-up

• Complete case records from all mental health services in the catchment areas

• Danish Psychiatric Central Case Register

• Cause of Death Register

• Central Civil Register (CPR)

• Statistic Denmark

• Database with all addresses for psychiatric nursing homes and staffed group homes

547 patients included

and randomised

272 patients allocated to

standard treatment

275 patients allocated to

OPUS team treatment and

treated for two years.

All patients were offered

standard treatment

for another three years

301 interview after

five years (56%)

Satisfaction with treatment 2 yWould you recommend this treatment to a friend?

0

10

20

30

40

50

60

Definitely I think so I don't think so Definitely not

OPUS team

Standard

DropDrop--outout

No outNo out--patient treatmentpatient treatment

0

5

10

15

20

25

30

35

1 år 2 år

Pro

cen

t

OPUS

Standard

Petersen et al, BMJ 2005

Psychotic dimensionPsychotic dimensionMean values

0

0,5

1

1,5

2

2,5

3

Baseline 1y 2y 5y

OPUS Standard

P=0.02 P=0.02 P= 0.31

Bertelsen et al, Arch Gen Psych 2008

Negative dimensionNegative dimensionMean values

0

0,5

1

1,5

2

2,5

Baseline 1y 2y 5y

OPUS Standard

P<0.001P<0.001 P=0.7

Bertelsen et al, Arch Gen Psych 2008

0

5

10

15

20

25

30

Baseline 1 y 2 y 5 y

OPUS team Standard

P = 0.03 P=0.04

Substance abuseSubstance abuse

Comorbid substance abuse (%)

P=0.49

Use of beddays during and after the

OPUS-trial

0

10

20

30

40

50

60

70

First two years Next three years

OPUS

Standard

Bertelsen et al, Arch Gen Psych 2008

Use of supported housing

Living in an institution

0

2

4

6

8

10

12

Supported housing 2y Supported housing 5y

Perc

en

t

OPUS

Standard

Use of supported housing

Living in an institution

0

20

40

60

80

100

120

First two years Nex three years

Days

OPUS

Standard

Bertelsen et al, Schiz res, 2008

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

2y 5y

7,912,5

72,652,8

7,5

15,2

19,5 19,4

Prognosis for patients with first episode psychosis after two and

five years

Recovery: GAF-F>60, remission and working or studying

Remission of psychotic and negative symptoms

Non-remission or not working or studying

Institutionalized: Living in supported housing or hospitalized more than 6 month last year

Probality of death (all causes) in the two

treatment groups as a function of time (days)

Hazard Function

TIME

200010000

Cu

m H

aza

rd,04

,03

,02

,01

0,00

-,01

Treatment group

Standard treatment

Standard treatment

-censored

Integrated treatment

Integrated treatment

-censored

Civil registration

system:

547 patients

RR 0.6 (0.2-1.6), P=

0.3

Power calculation:

1522 patients in each

treatment condition

necessary to detect a

difference between 2

% and 4 % mortality

Survival in the first 5 years

Probality of death by suicide in the two

treatment groups as a function of time (days)

Hazard Function

TIME

200010000

Cu

m H

aza

rd

,016

,014

,012

,010

,008

,006

,004

,002

0,000

-,002

Treatment group

Standard treatment

Standard treatment

-censored

Integrated treatment

Integrated treatment

-censored

Suicides in the first 5 years

Bertelsen et al,

Br J Psych, 2007

The Danish OPUS Trial

Conclusion:

• Psychotic and negative symptoms and substance

abuse was significantly better after two years of

intervention.

• Difference disappeared when patients in OPUS

treatment were transferred to standard treatment

after two years

• No difference between treatment groups at five-

year follow-up

The Danish OPUS Trial

Conclusion:

• Significant more satisfaction with treatment in

OPUS-team treated group after two-years

• Significantly better adherence in OPUS-team

treated group

The Danish OPUS TrialConclusion:

• Number of bed days was reduced with 22 percent in OPUS team group compared with standard treatment

• Even after the end of the experimental periode, patients in integrated treatment still had a lower use of bed days (17 percent lower)

• Fewer in the OPUS-treated group stayed in supported housing after five years

• OPUS treatment was cheaper and

better than standard treatment

Painkiller or driving licence

• Training effect

• Compensation

Rationale for early

assertive intervention

Compensation Learning

Rationale for early

assertive intervention

Compensation Learning

Rationale for early

assertive intervention

Compensation Learning

The relatives

• Effect after one year specialised assertive

treatment

Relatives stress-score, one-yearSocial Behaviour Assessment Schedule

5687N =

Intervention

STIT

global index of distress, 1 year

2,5

2,0

1,5

1,0

,5

0,0

347061193

OPUS vs

ST:

P= 0.04

Jeppesen,

Br J Psych, 2005,

Vol 87,Suppl 48

OPUS

Knowledge about schizophrenia,

relatives, one-year follow-up

5283N =

Intervention

STIT

knowledge score

at 1 year

40

30

20

10

0

21217

181

OPUS vs ST:

P= 0.02

OPUS

Satisfaction with treatment,

relatives, one-year follow-up

5184N =

Intervention

STIT

sum-score

of satisfaction

40

30

20

10

0

150

91

2354740

14

T-test

mean diff =

4.26 (2.7-5.9)

p<0.001OPUS

“Did the treatment help you to a better

understanding of your mentally ill

relative?”

csq8

4321

Percent

60

50

40

30

20

10

0

Intervention

IT

ST

Not at all Not very much To some degree Much better

OPUS

Clinical implications

• Intensive early intervention programmes

should be implemented

• Not to induce unnecessary loss of hope for

patients since approximately 45 % can

expect to reach remission of symptoms after

two years

Deinstitutionalisation revisited

Should the most severely ill among first

episode psychosis patients be treated with

hospital based rehabilitation?

46

578 patients includedin the OPUS-trial

272 patients allocated to Treatment As Usual;

N=29 + N=243

275 patients allocated to

Integrated Treatment;

N=34 + N=241

Randomisation 1

94 patients randomised

Hospital-based Rehabilitation;

N=31

Figure 1. The randomisations

Treatment As Usual;

N=29

Randomisation 2

484 patients randomised

TreatmentAs Usual;

N=243

IntegratedTreatment;

N=241

Integrated Treatment;

N=34

Number of days in psychiatric department or supported

housing during five years for first episode psychotic

patients randomised to OPUS, standard treatment or

hospitalbased rehabilitation

0

50

100

150

200

250

300

First

year,supervised

setting

Second year,

supervised

setting

Third year,

supervised

setting

Fourth year,

supervised

setting

Fifth year,

supervised

setting

Nu

mb

er

of

da

ys

pe

r y

ea

r

OPUS

Standard

HBR

Now we have build

excellent services for

first episode psychosis

Now we have build

excellent services for

first episode psychosis

But, what about the rest

of mental health services?

The extension trial OPUS II

The critical period?

400 patients treated in OPUS in two years

200 patients are

transferred to

CMHC, ACT-teams

or primary care

200 patients

continue OPUS

treatment for another

three years

Project will start 2009

The extension trial OPUS II

Primary outcome measure:

•Remission of negative and psychotic symptoms

Secondary outcome measures:

•Psychotic and negative symptoms

•Substance abuse

•User satisfaction

•Adherence to treatment

•Compliance with medication

•Suicidal behaviour

•Use of bed days

•Ability to live independently

•Labour market affiliation

The extension trial OPUS II

Power calculation

Two-years follow-up: simultaneous remission of

both negative and positive symptoms 38 percent

in OPUS vs 25 percent in standard.

We want to detect if this difference can be

maintained until five years follow up.

With the two-sided alpha level of significance of

0.05 and with a power of 0.80, and 25 percent

attrition, we will need to include 200 patients in

each group

The OPUS Trial• Merete Nordentoft

• Maj-Britt Abel

• Pia Jeppesen

• Anne Thorup

• Lone Petersen

• Johan Øhlenschlæger

• Runa Munkner

• Mette Bertelsen

• Britt Morthorst

• Gry Secher

• Marianne Melau

• Per Jørgensen

• Torben Christensen

• Gertrud Krarup

• Phoung Le Quack

• Ole Mors

• Preben Mortensen

• Stephen Austin

Psychiatric Centre Bispebjerg and

Sct Hans,

University of Copenhagen

Psychiatric

Universityhospital, Risskov,

The Danish OPUS TrialFunding:

Danish Ministry of Health,

Danish Ministry of Social Affairs,

Danish Medical Research Council,

University of Copenhagen,

Copenhagen Hospital Corporation,

Danish Medical Research Council,

Aarhus County,

Copenhagen Municipality,

The Stanley Medical Research Institute

Slagtermester Wørzners Foundation.

1110020

1110030

1110033

1110035

1110040

1110041

1110042

1110050

1110059

1110060

1110067

1110069

1110084

1110086

1110098

1110106

1110110

1110125

1110128

1110129

1110135

1110139

1110143

1110146

1110149

1110150

1110151

1110181

1110187

1110195

1110199

1110210

1120005

1120010

1120055

1120102

1120116

1130004

1130009

1130014

1130018

1130024

1130025

1130026

1130031

1130047

1130049

1130051

1130064

1130066

1130068

1130074

1130077

1130079

1130088

1130092

1130096

1130097

1130101

1130107

1130111

1130112

1130113

1130117

1130122

1130124

1130136

1130141

1130152

1130153

1130166

1140158

1140161

1140167

1140168

1140171

1140172

1140173

1140174

1140182

1140184

1140193

1140197

1140201

1140205

1140206

1140211

1140212

1140213

1140214

1140217

1140219

1140222

1140223

1140227

1140228

1140234

1140236

1140240

1140244

1140245

1140247

1140250

1140252

1140253

1140257

1140258

1140262

1140269

1140270

1140271

1140274

1140276

1140277

1210006

1210015

1210023

1210032

1210034

1210044

1210048

1210056

1210057

1210061

1210063

1210070

1210076

1210078

1210080

1210083

1210091

1210093

1210103

1210115

1210123

1210130

1210132

1210133

1210137

1210145

1210148

1210156

1210162

1210163

1210169

1210170

1210176

1210177

1210178

1210179

1210180

1210186

1210191

1210194

1210196

1210202

1210203

1210204

1220001

1220016

1220027

1220073

1220081

1220108

1220142

1230003

1230007

1230011

1230012

1230019

1230021

1230037

1230045

1230071

1230072

1230082

1230089

1230095

1230100

1230105

1230109

1230114

1230118

1230119

1230121

1230126

1230127

1230134

1230138

1230147

1230160

1230164

1240154

1240155

1240157

1240185

1240188

1240192

1240200

1240209

1240215

1240216

1240218

1240220

1240221

1240224

1240225

1240229

1240230

1240231

1240235

1240238

1240241

1240242

1240248

1240251

1240254

1240256

1240260

1240261

1240263

1240265

1240267

1240268

1240272

1240273

2140001

2140002

2140004

2140005

2140008

2140010

2140012

2140019

2140021

2140026

2140027

2140031

2140032

2140038

2140040

2140043

2140045

2140049

2140052

2140053

2140054

2140059

2140062

2140063

2140064

2140067

2140071

2150002

2150004

2150006

2150007

2150013

2150014

2150015

2150016

2150018

2150024

2150033

2150036

2150039

2150042

2150043

2150047

2150050

2150052

2150053

2150055

2150056

2150059

2150062

2150064

2150066

2150070

2150072

2150074

2150077

2150079

2150080

2150081

2160001

2160006

2160008

2160011

2160020

2160021

2160022

2160027

2160028

2170006

2170009

2170013

2170014

2170016

2170028

2170029

2170035

2170038

2170043

2170047

2170052

2180010

2180014

2180015

2180017

2180023

2180026

2180032

2190005

2190006

2190008

2190012

2190015

2190017

2190018

2190020

2190022

2190023

2190025

2190026

2190032

2190037

2190040

2190044

2190045

2240006

2240009

2240011

2240013

2240020

2240025

2240029

2240030

2240033

2240042

2240044

2240048

2240056

2240058

2240060

2240068

2240069

2240075

2240076

2240077

2250003

2250005

2250008

2250010

2250011

2250012

2250019

2250020

2250021

2250026

2250027

2250031

2250032

2250037

2250040

2250041

2250044

2250045

2250048

2250051

2250054

2250057

2250060

2250063

2250065

2250067

2250069

2250071

2250073

2250075

2250076

2260002

2260003

2260004

2260005

2260013

2260014

2260015

2260017

2260018

2260023

2260024

2260026

2270004

2270008

2270011

2270015

2270021

2270022

2270024

2270025

2270030

2270036

2270037

2270039

2270042

2270048

2270049

2280001

2280002

2280006

2280007

2280009

2280011

2280020

2280022

2280025

2280028

2280035

2290002

2290004

2290007

2290011

2290014

2290019

2290028

2290031

2290033

2290041

2290047

2540007

2540018

2540041

2540051

2540057

2550009

2550025

2550038

2550068

2560007

2560010

2560012

2560025

2570005

2570023

2570026

2570032

2570033

2570046

2570050

2570051

2580018

2590009

2590010

2590013

2590038

2590049

The

Danish

OPUS

trial

[email protected]

Thank you for your attention